About Escientia Advanced Sciences Private Limited
Data last updated:
Escientia Advanced Sciences Private Limited is a private limited company based in Shameerpet, Telangana, India, a subsidiary of Deccan Advanced Sciences Pvt Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 February 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2013PTC085962. Its GSTIN is 37AADCE3157C1ZY (Andhra Pradesh).
The company has an authorised share capital of ₹22 Cr and a paid-up capital of ₹21.49 Cr. It is led by directors including Pendri Kiran Reddy and Dandu Chakradhar.
Its last annual general meeting (AGM) was held on 20 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Surveyno.542/02 Plot No:Ds /14 Ikp Knowledge Park Kolthur Village, Shameerpet, Telangana, India – 500078.
As per the financials filed for FY 2024, the company reported a revenue of ₹423.15 Cr, a growth of 114% compared to the previous year. For the same year it recorded a net profit of ₹155.3 Cr (net margin 36.7%) and EBITDA of ₹226.43 Cr (EBITDA margin 53.5%). Revenue has grown at a compounded annual rate (CAGR) of 97% over three years and 299% over five years.
The company has about 295 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Escientia Lifesciences. As per MCA filings, the company has open charges of ₹100 Cr and satisfied charges of ₹85 Cr on record. Court records list 37 cases involving the company, including 2 filed by the company and 35 filed against it; 10 cases are pending. The company has 7 deals on record (5 rights issues, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹17.67 Cr; the latest was in August 2020. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Hazelo Lab Private Limited with revenue of ₹431.64 Cr. The company has 11 MSME Form 1 returns on record between 2019 and 2024, listing 143 overdue payments to 36 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website escientia.com.
Company details
CIN history
Escientia Advanced Sciences has one previous CIN (Corporate Identification Number): U24100AP2013PTC085962. The current CIN is U24100TG2013PTC085962, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2013PTC085962 | Current |
| U24100AP2013PTC085962 | Previous |
Contact details
Escientia Advanced Sciences Private Limited's registered office is in Shameerpet, Telangana. Its website is escientia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSurveyno.542/02 Plot No:Ds /14 Ikp Knowledge Park Kolthur Village, Shameerpet, Telangana, India – 500078
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Escientia Advanced Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Escientia Advanced Sciences operates one associated brand: Escientia Lifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Technology-oriented manufacturing services for pharmaceutical and biotechnology firms are provided. | escientia.com |
Business activity
The main business activity of Escientia Advanced Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Escientia Advanced Sciences Private Limited, buy the company report.
Financials of Escientia Advanced Sciences Private Limited
FY 2024 filings availableEscientia Advanced Sciences Private Limited reported revenue of ₹423.15 Cr (up 114% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 299% over five years, including 114% growth in the latest year. EBITDA rose 133% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹226.43 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹155.3 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 53.5% | ||||
| Net Profit Margin | 36.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Escientia Advanced Sciences Private Limited, buy the company report.
Board of directors and KMP of Escientia Advanced Sciences Private Limited
Escientia Advanced Sciences Private Limited currently reports 5 directors and 1 key managerial person. 7 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Rao Korada | Cfo | 01 Mar 2021 | 5 Years 7 Months | Current |
| Pendri Kiran Reddy Also directs: Escientia Biopharma Private Limited | Director | 27 Feb 2013 | 13 Years 7 Months | Current |
| Dandu Chakradhar | Director | 19 Aug 2020 | 6 Years 2 Months | Current |
| Ajit Alexander George Also directs: Escientia Biopharma Private Limited | Director | 24 Jun 2023 | 3 Years 4 Months | Current |
| Yadagiri R Pendri | Director | 27 Feb 2013 | 13 Years 7 Months | Current |
| Vivek Vasant Save Also directs: Escientia Biopharma Private Limited | Director | 24 Jun 2023 | 3 Years 4 Months | Current |
Peer comparison
Escientia Advanced Sciences Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hazelo Lab Private Limited | ₹431.64 Cr (FY 2024) | 3.0% | Chityal, Telangana, India | |||
| Zydus Hospira Oncology Private Limited | ₹430.96 Cr (FY 2025) | 66.0% | Village Matoda Tal Sanand, Gujarat, India | |||
| Halewood Laboratories Private Limited | ₹430.29 Cr (FY 2025) | 20.0% | Ahmedabad, Gujarat, India | |||
| Milan Laboratories (India) Private Limited | ₹429.23 Cr (FY 2024) | 42.0% | Thane, Maharashtra, India | |||
| Escientia Advanced Sciences Private Limitedthis company | ₹423.15 Cr (FY 2024) | ₹155.3 Cr | 36.7% | 114.0% | 295 | Shameerpet, Telangana, India |
| Recipharm Pharmaservices Private Limited | ₹421.11 Cr (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| Albert David Ltd | ₹420.01 Cr (FY 2024) | 18.0% | Kolkata, West Bengal, India | |||
| Aspiro Pharma Limited | ₹418.29 Cr (FY 2025) | 147.0% | Markook, Telangana, India | |||
| Scott-Edil Advance Research Laboratories & Education Limited | ₹418.23 Cr (FY 2025) | 17.0% | Chandigarh, India | |||
| Visa Drugs & Pharmaceuticals Private Limited | ₹414.04 Cr (FY 2016) | 32.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Escientia Advanced Sciences Private Limited, buy the company report.
Auditor
Escientia Advanced Sciences Private Limited is audited by M S K A & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M S K A & ASSOCIATES | FY 2022 | 105047W |
Shareholding
The shareholding of Escientia Advanced Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Escientia Advanced Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Nov 2020 | 100385778 | Others | ₹100 Cr | Open | |
| 29 Jun 2021 | 100461699 | Hdfc Bank Limited | ₹65 Cr | Satisfied | |
| 02 Nov 2020 | 100385555 | Others | ₹20 Cr | Satisfied |
To see the full charge records of Escientia Advanced Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Escientia Advanced Sciences Private Limited has 7 deals on record (5 rights issues, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹17.67 Cr; the latest was in August 2020.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: Deccan Advanced Sciences Private Limited , an individual Seller: an individual |
| Feb 2020 | Rights issue | ₹6.42 Cr | Investors: an individual |
| Aug 2018 | Rights issue | ₹62.77 Cr | Investors: an individual |
| Jan 2017 | Rights issue | ₹77 Cr | Investors: an individual |
| Apr 2015 | Rights issue | ₹95.89 Cr | Investors: an individual |
To see the full deal history of Escientia Advanced Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Escientia Advanced Sciences Private Limited has 37 court cases on record: 2 filed by Escientia Advanced Sciences, 35 filed against it. 10 cases are pending and 27 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 21 | 21 | 7 |
| NCLT | 8 | 8 | 1 |
| High courts | 4 | 2 | 1 |
| District courts | 2 | 2 | 1 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 37)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT Chennai | Company appeal | Filed against the company by Deccan Advanced Sciences Pvt Ltd | Pending |
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed against the company by Deccan Advanced Sciences Pvt Ltd | Pending |
| NCLT, NCLT Hyderabad | Court case (Ivn.P) | Filed against the company by Escientia Life Sciences | Pending |
| District court, Hyderabad Central, Telangana | Court case (A.R.B.O.P) | Filed against the company by Senior Divisional Manager, the Oriental Insurance Company Ltd. | Pending |
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed against the company by Deccan Advanced Sciences Pvt Ltd | Disposed |
To see the full case history of Escientia Advanced Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Escientia Advanced Sciences Private Limited has 11 MSME Form 1 returns on record between 2019 and 2024, listing 143 overdue payments to 36 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 36)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ap Chemicals and Technologies | |||
| an individual supplier | |||
| Neoteric Engineers | |||
| Centaur Fsa Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Escientia Advanced Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Escientia Advanced Sciences Private Limited has a workforce of 295 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Escientia Advanced Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AADCE3157C1ZY | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Escientia Advanced Sciences Private Limited, buy the company report.
Recent activity
Escientia Advanced Sciences Private Limited has 11 board changes on record since 2013: 6 appointments and 5 cessations. The latest: Chakrapani Pallerlamudi Tirumala ceased to be Company Secretary on 11 Mar 2024.
9 earlier events are in the company report.
Frequently asked questions
Escientia Advanced Sciences is an active private limited company based in Shameerpet, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 February 2013 (13+ years old) and is registered under CIN U24100TG2013PTC085962.
Escientia Advanced Sciences has 6 current directors and KMP:
- Pendri Kiran Reddy - Director
- Dandu Chakradhar - Director
- Ajit Alexander George - Director
- Yadagiri R Pendri - Director
- Vivek Vasant Save - Director
- Srinivasa Rao Korada - Cfo
The latest financial statements of Escientia Advanced Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 20 December 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Escientia Advanced Sciences is 37AADCE3157C1ZY, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Escientia Advanced Sciences is U24100TG2013PTC085962. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Escientia Advanced Sciences has 37 court cases on record: 2 filed by the company and 35 filed against it. 10 are pending. Most are in the nclat.
Escientia Advanced Sciences was incorporated on 27 February 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
Escientia Advanced Sciences has 7 deals on record (5 rights issues, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹17.67 Cr; the latest was in August 2020.
The peers of Escientia Advanced Sciences by revenue are Hazelo Lab Private Limited, Zydus Hospira Oncology Private Limited, Halewood Laboratories Private Limited, Milan Laboratories (India) Private Limited, Recipharm Pharmaservices Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chakrapani Pallerlamudi Tirumala ceased to be Company Secretary on 11 Mar 2024. Ajit Alexander George was appointed as Director on 24 Jun 2023. Vivek Vasant Save was appointed as Director on 24 Jun 2023. Escientia Advanced Sciences has 11 board changes on record in total.
Escientia Advanced Sciences has 11 MSME Form 1 returns on record between 2019 and 2024, listing 143 overdue payments to 36 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Escientia Advanced Sciences can be reached through the website escientia.com. Its registered office is in Shameerpet, Telangana, India.